Currently, the share price for Senores Pharmaceuticals Ltd. is delayed. Login to view live prices.
Senores Pharmaceuticals Ltd.
₹576.15
NSE
-- ( -- %) 1D
Earnings Per Share
Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
| Particulars (In Cr) | Dec 2024 | Y/Y Change |
|---|---|---|
| Operating Revenue | 103.02 | -51.98% |
| Other Income | 5.16 | +82.98% |
| Total Income | 108.18 | -50.23% |
| Total Expenditure | 77.33 | -55.29% |
| EBIDT | 30.85 | -30.52% |
| Depreciation | 4.20 | -58.08% |
| Interest | 6.16 | -34.81% |
| Tax | 4.06 | -152.25% |
| Net Profit | 17.18 | -45.37% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Total Current Assets | 250.91 | +388.72% |
| Total Non-Current Assets | 370.97 | +365.34% |
| Fixed assets | 294.30 | +376.91% |
| Total assets | 621.88 | +374.54% |
| Total Current Liabilities | 247.50 | +377.06% |
| Total Non-Current Liabilities | 142.67 | +323.73% |
| Total Capital Plus Liabilities | 621.88 | +374.54% |
| Total Shareholder Funds | 204.27 | +348.95% |
| Total Debt to Equity | 1.22 | -8.96% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Cash from Operating Activity | -19.87 | +1739.81% |
| Cash from Financing Activities | 86.98 | +88.06% |
| Cash from Investing Activities | -54.66 | +13.19% |
| Net Cash Flow | 12.45 | -499.04% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer